SCI & TECH● LOW5d ago · Aug 28, 2026, 3:39 PM
BioNTech falls as it ends mid-stage trial of mRNA colorectal cancer vaccine
Seeking Alpha Tech · global
BioNTech's shares fell after the company ended a mid-stage clinical trial for its mRNA colorectal cancer vaccine, marking a setback in its drug development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH1h agoTrump Justice Department weighs in on OpenAI copyright case , citing national interestnydailynews.com · United StatesSCI & TECH1h agoHow AI is being used to track art stolen by the Nazisksmu.org · United StatesSCI & TECH1h agoHow much influence do tech giants have in American schools ? : NPRnpr.org · United StatesSCI & TECH1h agoTrump administration backs OpenAI in New York Time copyright case over training of chatbotsdailynews.com · United States